Last 12 months
Inside the activity.
0 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 12, 2026 Filed Oct 14, 2026 21:51 UTC |
Martinez Matthew AaronChief Legal Officer
|
GrantRestricted Stock Units · Derivative | 5,411 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-26-000073 · wk-form4_1792014701.xml · derivative · entry 2 Martinez Matthew Aaron · CIK 0002092269 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,411 Underlying: Common Stock · 5,411 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: These three-year cliff Restricted Stock Units ("3-year RSUs") granted on October 12, 2026 are scheduled to vest on August 15, 2029. Vested shares will be delivered to the Reporting Person on the vest date. Notwithstanding the foregoing, in the event of Closing, the 3-year RSUs will vest as described in footnote 5. F5 · derivative.exercise_date: Upon Closing, (i) each tranche of 3-year RSUs outstanding and unvested as of immediately prior to the Closing shall vest on a pro-rata basis as of immediately prior to the Closing , (ii) the 3-year RSUs to the extent outstanding and vested as of Closing (determined after applying clause (i) above) shall be cancelled and converted as of Closing into the right to receive $18.90 per share in cash, and (iii) any portion that remains unvested as of Closing shall be automatically forfeited at Closing without consideration. F4 · derivative.expiration_date: These three-year cliff Restricted Stock Units ("3-year RSUs") granted on October 12, 2026 are scheduled to vest on August 15, 2029. Vested shares will be delivered to the Reporting Person on the vest date. Notwithstanding the foregoing, in the event of Closing, the 3-year RSUs will vest as described in footnote 5. F5 · derivative.expiration_date: Upon Closing, (i) each tranche of 3-year RSUs outstanding and unvested as of immediately prior to the Closing shall vest on a pro-rata basis as of immediately prior to the Closing , (ii) the 3-year RSUs to the extent outstanding and vested as of Closing (determined after applying clause (i) above) shall be cancelled and converted as of Closing into the right to receive $18.90 per share in cash, and (iii) any portion that remains unvested as of Closing shall be automatically forfeited at Closing without consideration. Read SEC document |
| October 12, 2026 Filed Oct 14, 2026 21:51 UTC |
Martinez Matthew AaronChief Legal Officer
|
GrantRestricted Stock Units · Derivative | 5,411 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-26-000073 · wk-form4_1792014701.xml · derivative · entry 1 Martinez Matthew Aaron · CIK 0002092269 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,411 Underlying: Common Stock · 5,411 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These four-year Restricted Stock Units ("4-year RSUs") granted on October 12, 2026 are scheduled to vest 50% on August 15, 2028 and 50% on August 15, 2030. Vested shares will be delivered to the Reporting Person on the vest date. Notwithstanding the foregoing, if the acquisition of the Issuer by Teledyne Technologies Incorporated, pursuant to that certain merger agreement dated August 10, 2026 (the "Merger Agreement") is consummated (the "Closing"), the 4-year RSUs will vest as described in footnote 3. F3 · derivative.exercise_date: Upon Closing, (i) each tranche of 4-year RSUs outstanding and unvested as of immediately prior to the Closing shall vest on a pro-rata basis as of immediately prior to the Closing, (ii) the 4-year RSUs to the extent outstanding and vested as of Closing (determined after applying clause (i) above) shall be cancelled and converted into the right to receive $18.90 per share in cash, and (iii) any portion that remains unvested as of Closing shall be automatically forfeited at Closing without consideration. F2 · derivative.expiration_date: These four-year Restricted Stock Units ("4-year RSUs") granted on October 12, 2026 are scheduled to vest 50% on August 15, 2028 and 50% on August 15, 2030. Vested shares will be delivered to the Reporting Person on the vest date. Notwithstanding the foregoing, if the acquisition of the Issuer by Teledyne Technologies Incorporated, pursuant to that certain merger agreement dated August 10, 2026 (the "Merger Agreement") is consummated (the "Closing"), the 4-year RSUs will vest as described in footnote 3. F3 · derivative.expiration_date: Upon Closing, (i) each tranche of 4-year RSUs outstanding and unvested as of immediately prior to the Closing shall vest on a pro-rata basis as of immediately prior to the Closing, (ii) the 4-year RSUs to the extent outstanding and vested as of Closing (determined after applying clause (i) above) shall be cancelled and converted into the right to receive $18.90 per share in cash, and (iii) any portion that remains unvested as of Closing shall be automatically forfeited at Closing without consideration. Read SEC document |
| September 14, 2026 Filed Sep 15, 2026 21:44 UTC |
Kunkel Jay K.Director
|
SaleCommon Stock | 8,121 | $18.48 | $150,076.08 |
DisclosureSEC source: 0001592005-26-000007 · wk-form4_1789508684.xml · nonDerivative · entry 1 Kunkel Jay K. · CIK 0001592005 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,329 Read SEC document |
| September 11, 2026 Filed Sep 15, 2026 21:44 UTC |
Maheshwari ShubhamChief Financial Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 160,944 | $0.00 Strike: $13.61 | $0.00 |
DisclosureSEC source: 0001607969-26-000002 · wk-form4_1789508688.xml · derivative · entry 3 Maheshwari Shubham · CIK 0001607969 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 160,944 shares Expires 2030-08-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These Performance Stock Options were subject to a four-year vesting schedule. 25% of the total number of options vested on August 15, 2021 and the remaining options vested monthly thereafter on a pro rata basis. Read SEC document |
| September 11, 2026 Filed Sep 15, 2026 21:44 UTC |
Maheshwari ShubhamChief Financial Officer
|
SaleCommon Stock | 130,000 | $18.46 | $2,400,060.00 |
DisclosureSEC source: 0001607969-26-000002 · wk-form4_1789508688.xml · nonDerivative · entry 2 Maheshwari Shubham · CIK 0001607969 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,972 F2 · shares: The sales reported on this Form 4 were effected pursuant to a broker-assisted sell-to-cover exercise of fully vested options. The shares were sold solely to cover the aggregate exercise price, applicable tax withholdings and broker's fees. The reporting person retained all remaining shares acquired upon exercise. F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.460 to $18.470. The reporting person undertakes to provide Varex Imaging Corporation, any security holder of Varex Imaging Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| September 11, 2026 Filed Sep 15, 2026 21:44 UTC |
Maheshwari ShubhamChief Financial Officer
|
Exercise / conversionCommon Stock | 160,944 | $13.61 | $2,190,447.84 |
DisclosureSEC source: 0001607969-26-000002 · wk-form4_1789508688.xml · nonDerivative · entry 1 Maheshwari Shubham · CIK 0001607969 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 269,972 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 2,137 shares purchased under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan since the last Form 4 filing of the reporting person. Read SEC document |
| August 14, 2026 Filed Aug 18, 2026 20:29 UTC |
Aranki Karen LChief Human Resources Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,974 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-26-000071 · wk-form4_1787084953.xml · derivative · entry 3 Aranki Karen L · CIK 0002011723 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,975 Underlying: Common Stock · 3,974 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Restricted Stock Units granted on August 15, 2024 vested 50% on August 15, 2026, with the remaining 50% scheduled to vest on August 15, 2028. Vested shares will be delivered to the reporting person upon vesting. F3 · derivative.expiration_date: These Restricted Stock Units granted on August 15, 2024 vested 50% on August 15, 2026, with the remaining 50% scheduled to vest on August 15, 2028. Vested shares will be delivered to the reporting person upon vesting. Read SEC document |
| August 14, 2026 Filed Aug 18, 2026 20:29 UTC |
Aranki Karen LChief Human Resources Officer
|
Tax withholdingCommon Stock | 1,145 | $18.49 | $21,171.05 |
DisclosureSEC source: 0001681622-26-000071 · wk-form4_1787084953.xml · nonDerivative · entry 2 Aranki Karen L · CIK 0002011723 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,748 F2 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. Read SEC document |
| August 14, 2026 Filed Aug 18, 2026 20:29 UTC |
Aranki Karen LChief Human Resources Officer
|
Exercise / conversionCommon Stock | 3,974 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-26-000071 · wk-form4_1787084953.xml · nonDerivative · entry 1 Aranki Karen L · CIK 0002011723 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,893 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| March 20, 2026 Filed Mar 23, 2026 16:40 UTC |
Kunkel Jay K.Director
|
SaleCommon Stock | 4,510 | $11.14 | $50,241.40 |
DisclosureSEC source: 0001592005-26-000005 · wk-form4_1774298442.xml · nonDerivative · entry 1 Kunkel Jay K. · CIK 0001592005 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,450 F1 · price: All individual shares were sold at a price of $11.14 Read SEC document |
| February 12, 2026 Filed Feb 13, 2026 21:08 UTC |
Rosebrough Walter M JrDirector
|
GrantDeferred Stock Units · Derivative | 14,947 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-26-000027 · wk-form4_1771016879.xml · derivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,947 Underlying: Common Stock · 14,947 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document |
| February 12, 2026 Filed Feb 13, 2026 21:07 UTC |
TSINGOS CHRISTINE ADirector
|
GrantDeferred Stock Units · Derivative | 12,331 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-26-000026 · wk-form4_1771016873.xml · derivative · entry 1 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,331 Underlying: Common Stock · 12,331 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document |
| February 12, 2026 Filed Feb 13, 2026 16:07 UTC |
GUERTIN TIMOTHY EDirector
|
GrantDeferred Stock Units · Derivative | 12,331 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-26-000025 · wk-form4_1771016867.xml · derivative · entry 1 GUERTIN TIMOTHY E · CIK 0001217440 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,331 Underlying: Common Stock · 12,331 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document |
| February 12, 2026 Filed Feb 13, 2026 16:08 UTC |
Bardwell KathleenDirector
|
GrantDeferred Stock Units · Derivative | 12,331 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-26-000029 · wk-form4_1771016891.xml · derivative · entry 1 Bardwell Kathleen · CIK 0001532367 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,331 Underlying: Common Stock · 12,331 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document |
| February 12, 2026 Filed Feb 13, 2026 16:08 UTC |
Kunkel Jay K.Director
|
GrantDeferred Stock Units · Derivative | 12,331 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-26-000028 · wk-form4_1771016885.xml · derivative · entry 1 Kunkel Jay K. · CIK 0001592005 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,331 Underlying: Common Stock · 12,331 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document |
| February 12, 2026 Filed Feb 13, 2026 21:07 UTC |
Chertoff Jocelyn DDirector
|
GrantDeferred Stock Units · Derivative | 12,331 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-26-000024 · wk-form4_1771016856.xml · derivative · entry 1 Chertoff Jocelyn D · CIK 0001701927 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,331 Underlying: Common Stock · 12,331 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document |
| February 09, 2026 Filed Feb 9, 2026 21:14 UTC |
Rosebrough Walter M JrDirector
|
Exercise / conversionDeferred Stock Units · Derivative | 10,339 | $0.00 | $0.00 |
DisclosureSEC source: 0001413087-26-000003 · wk-form4_1770671682.xml · derivative · entry 2 Rosebrough Walter M Jr · CIK 0001413087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,339 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units were issued on February 9, 2023, vested on February 8, 2024, and delivery of the vested Deferred Stock Units, in the form of common stock occurred on February 9, 2026, the third anniversary of the date of grant. F2 · derivative.expiration_date: These Deferred Stock Units were issued on February 9, 2023, vested on February 8, 2024, and delivery of the vested Deferred Stock Units, in the form of common stock occurred on February 9, 2026, the third anniversary of the date of grant. Read SEC document |
| February 09, 2026 Filed Feb 9, 2026 21:14 UTC |
Rosebrough Walter M JrDirector
|
Exercise / conversionCommon Stock | 10,339 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001413087-26-000003 · wk-form4_1770671682.xml · nonDerivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,654 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 09, 2026 Filed Feb 9, 2026 21:13 UTC |
TSINGOS CHRISTINE ADirector
|
Exercise / conversionDeferred Stock Units · Derivative | 8,483 | $0.00 | $0.00 |
DisclosureSEC source: 0001278861-26-000004 · wk-form4_1770671631.xml · derivative · entry 2 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,483 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units were issued on February 9, 2023, vested on February 8, 2024, and delivery of the vested Deferred Stock Units, in the form of common stock occurred on February 9, 2026, the third anniversary of the date of grant. F2 · derivative.expiration_date: These Deferred Stock Units were issued on February 9, 2023, vested on February 8, 2024, and delivery of the vested Deferred Stock Units, in the form of common stock occurred on February 9, 2026, the third anniversary of the date of grant. Read SEC document |
| February 09, 2026 Filed Feb 9, 2026 21:13 UTC |
TSINGOS CHRISTINE ADirector
|
Exercise / conversionCommon Stock | 8,483 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001278861-26-000004 · wk-form4_1770671631.xml · nonDerivative · entry 1 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,655 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 09, 2026 Filed Feb 9, 2026 16:14 UTC |
GUERTIN TIMOTHY EDirector
|
Exercise / conversionDeferred Stock Units · Derivative | 8,483 | $0.00 | $0.00 |
DisclosureSEC source: 0001217440-26-000002 · wk-form4_1770671663.xml · derivative · entry 2 GUERTIN TIMOTHY E · CIK 0001217440 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,483 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units were issued on February 9, 2023, vested on February 8, 2024, and delivery of the vested Deferred Stock Units, in the form of common stock occurred on February 9, 2026, the third anniversary of the date of grant. F2 · derivative.expiration_date: These Deferred Stock Units were issued on February 9, 2023, vested on February 8, 2024, and delivery of the vested Deferred Stock Units, in the form of common stock occurred on February 9, 2026, the third anniversary of the date of grant. Read SEC document |
| February 09, 2026 Filed Feb 9, 2026 16:14 UTC |
GUERTIN TIMOTHY EDirector
|
Exercise / conversionCommon Stock | 8,483 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001217440-26-000002 · wk-form4_1770671663.xml · nonDerivative · entry 1 GUERTIN TIMOTHY E · CIK 0001217440 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,777 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 09, 2026 Filed Feb 9, 2026 16:14 UTC |
Bardwell KathleenDirector
|
Exercise / conversionDeferred Stock Units · Derivative | 8,483 | $0.00 | $0.00 |
DisclosureSEC source: 0001532367-26-000002 · wk-form4_1770671647.xml · derivative · entry 2 Bardwell Kathleen · CIK 0001532367 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,483 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units were issued on February 9, 2023, vested on February 8, 2024, and delivery of the vested Deferred Stock Units, in the form of common stock occurred on February 9, 2026, the third anniversary of the date of grant. F2 · derivative.expiration_date: These Deferred Stock Units were issued on February 9, 2023, vested on February 8, 2024, and delivery of the vested Deferred Stock Units, in the form of common stock occurred on February 9, 2026, the third anniversary of the date of grant. Read SEC document |
| February 09, 2026 Filed Feb 9, 2026 16:14 UTC |
Bardwell KathleenDirector
|
Exercise / conversionCommon Stock | 8,483 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001532367-26-000002 · wk-form4_1770671647.xml · nonDerivative · entry 1 Bardwell Kathleen · CIK 0001532367 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,102 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 09, 2026 Filed Feb 9, 2026 21:15 UTC |
Chertoff Jocelyn DDirector
|
Exercise / conversionDeferred Stock Units · Derivative | 8,483 | $0.00 | $0.00 |
DisclosureSEC source: 0001701927-26-000003 · wk-form4_1770671698.xml · derivative · entry 2 Chertoff Jocelyn D · CIK 0001701927 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,483 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units were issued on February 9, 2023, vested on February 8, 2024, and delivery of the vested Deferred Stock Units, in the form of common stock occurred on February 9, 2026, the third anniversary of the date of grant. F2 · derivative.expiration_date: These Deferred Stock Units were issued on February 9, 2023, vested on February 8, 2024, and delivery of the vested Deferred Stock Units, in the form of common stock occurred on February 9, 2026, the third anniversary of the date of grant. Read SEC document |
| February 09, 2026 Filed Feb 9, 2026 21:15 UTC |
Chertoff Jocelyn DDirector
|
Exercise / conversionCommon Stock | 8,483 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001701927-26-000003 · wk-form4_1770671698.xml · nonDerivative · entry 1 Chertoff Jocelyn D · CIK 0001701927 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,194 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 09, 2026 Filed Feb 10, 2026 16:04 UTC |
Kunkel Jay K.Director
|
Exercise / conversionDeferred Stock Units · Derivative | 8,483 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-26-000014 · wk-form4_1770757466.xml · derivative · entry 2 Kunkel Jay K. · CIK 0001592005 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,483 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units were issued on February 9, 2023, vested on February 8, 2024, and delivery of the vested Deferred Stock Units, in the form of common stock occurred on February 9, 2026, the third anniversary of the date of grant. F2 · derivative.expiration_date: These Deferred Stock Units were issued on February 9, 2023, vested on February 8, 2024, and delivery of the vested Deferred Stock Units, in the form of common stock occurred on February 9, 2026, the third anniversary of the date of grant. Read SEC document |
| February 09, 2026 Filed Feb 10, 2026 16:04 UTC |
Kunkel Jay K.Director
|
Exercise / conversionCommon Stock | 8,483 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-26-000014 · wk-form4_1770757466.xml · nonDerivative · entry 1 Kunkel Jay K. · CIK 0001592005 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,960 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 21:33 UTC |
Aranki Karen LChief Human Resources Officer
|
GrantPerformance Stock Units · Derivative | 2,633 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-25-000134 · wk-form4_1766007220.xml · derivative · entry 2 Aranki Karen L · CIK 0002011723 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,633 Underlying: Common Stock · 2,633 shares Expires not disclosed F1 · derivative.exercise_price: Each PSU represents a contingent right to receive one share of Varex Imaging common stock, subject to the achievement of applicable performance criteria. F3 · derivative.exercise_date: On December 10, 2024, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of Fiscal Year 2027, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date. F3 · derivative.expiration_date: On December 10, 2024, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of Fiscal Year 2027, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 21:33 UTC |
Aranki Karen LChief Human Resources Officer
|
GrantPerformance Stock Units · Derivative | 2,155 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-25-000134 · wk-form4_1766007220.xml · derivative · entry 1 Aranki Karen L · CIK 0002011723 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,510 Underlying: Common Stock · 2,155 shares Expires not disclosed F1 · derivative.exercise_price: Each PSU represents a contingent right to receive one share of Varex Imaging common stock, subject to the achievement of applicable performance criteria. F2 · derivative.exercise_date: On December 10, 2023, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of Fiscal Year 2026, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date. F2 · derivative.expiration_date: On December 10, 2023, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of Fiscal Year 2026, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 16:34 UTC |
Jonaitis Mark S.SVP and GM, X-Ray Sources
|
GrantPerformance Stock Units · Derivative | 3,134 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-25-000136 · wk-form4_1766007237.xml · derivative · entry 2 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,134 Underlying: Common Stock · 3,134 shares Expires not disclosed F1 · derivative.exercise_price: Each PSU represents a contingent right to receive one share of Varex Imaging common stock, subject to the achievement of applicable performance criteria. F3 · derivative.exercise_date: On December 10, 2024, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of fiscal year 2027, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date. F3 · derivative.expiration_date: On December 10, 2024, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of fiscal year 2027, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 16:34 UTC |
Jonaitis Mark S.SVP and GM, X-Ray Sources
|
GrantPerformance Stock Units · Derivative | 2,565 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-25-000136 · wk-form4_1766007237.xml · derivative · entry 1 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,178 Underlying: Common Stock · 2,565 shares Expires not disclosed F1 · derivative.exercise_price: Each PSU represents a contingent right to receive one share of Varex Imaging common stock, subject to the achievement of applicable performance criteria. F2 · derivative.exercise_date: On December 10, 2023, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of fiscal year 2026, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date. F2 · derivative.expiration_date: On December 10, 2023, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of fiscal year 2026, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 16:33 UTC |
SANYAL SUNNYDirector · President and CEO
|
GrantPerformance Stock Units · Derivative | 18,801 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-25-000135 · wk-form4_1766007229.xml · derivative · entry 2 SANYAL SUNNY · CIK 0001599398 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,801 Underlying: Common Stock · 18,801 shares Expires not disclosed F1 · derivative.exercise_price: Each PSU represents a contingent right to receive one share of Varex Imaging common stock, subject to the achievement of applicable performance criteria. F3 · derivative.exercise_date: On December 10, 2024, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of fiscal year 2027, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date. F3 · derivative.expiration_date: On December 10, 2024, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of fiscal year 2027, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 16:33 UTC |
SANYAL SUNNYDirector · President and CEO
|
GrantPerformance Stock Units · Derivative | 15,394 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-25-000135 · wk-form4_1766007229.xml · derivative · entry 1 SANYAL SUNNY · CIK 0001599398 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,075 Underlying: Common Stock · 15,394 shares Expires not disclosed F1 · derivative.exercise_price: Each PSU represents a contingent right to receive one share of Varex Imaging common stock, subject to the achievement of applicable performance criteria. F2 · derivative.exercise_date: On December 10, 2023, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of fiscal year 2026, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date. F2 · derivative.expiration_date: On December 10, 2023, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of fiscal year 2026, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 16:34 UTC |
Maheshwari ShubhamChief Financial Officer
|
GrantPerformance Stock Units · Derivative | 5,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-25-000138 · wk-form4_1766007254.xml · derivative · entry 2 Maheshwari Shubham · CIK 0001607969 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,520 Underlying: Common Stock · 5,520 shares Expires not disclosed F1 · derivative.exercise_price: Each PSU represents a contingent right to receive one share of Varex Imaging common stock, subject to the achievement of applicable performance criteria. F3 · derivative.exercise_date: On December 10, 2024, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of fiscal year 2027, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date. F3 · derivative.expiration_date: On December 10, 2024, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of fiscal year 2027, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 16:34 UTC |
Maheshwari ShubhamChief Financial Officer
|
GrantPerformance Stock Units · Derivative | 4,515 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-25-000138 · wk-form4_1766007254.xml · derivative · entry 1 Maheshwari Shubham · CIK 0001607969 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,354 Underlying: Common Stock · 4,515 shares Expires not disclosed F1 · derivative.exercise_price: Each PSU represents a contingent right to receive one share of Varex Imaging common stock, subject to the achievement of applicable performance criteria. F2 · derivative.exercise_date: On December 10, 2023, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of fiscal year 2026, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date. F2 · derivative.expiration_date: On December 10, 2023, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of fiscal year 2026, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 21:34 UTC |
Hartmann AndrewSVP and GM, Detectors
|
GrantPerformance Stock Units · Derivative | 3,134 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-25-000137 · wk-form4_1766007245.xml · derivative · entry 2 Hartmann Andrew · CIK 0001846805 · SVP and GM, Detectors 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,134 Underlying: Common Stock · 3,134 shares Expires not disclosed F1 · derivative.exercise_price: Each PSU represents a contingent right to receive one share of Varex Imaging common stock, subject to the achievement of applicable performance criteria. F3 · derivative.exercise_date: On December 10, 2024, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of fiscal year 2027, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date. F3 · derivative.expiration_date: On December 10, 2024, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of fiscal year 2027, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 21:34 UTC |
Hartmann AndrewSVP and GM, Detectors
|
GrantPerformance Stock Units · Derivative | 2,565 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-25-000137 · wk-form4_1766007245.xml · derivative · entry 1 Hartmann Andrew · CIK 0001846805 · SVP and GM, Detectors 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,178 Underlying: Common Stock · 2,565 shares Expires not disclosed F1 · derivative.exercise_price: Each PSU represents a contingent right to receive one share of Varex Imaging common stock, subject to the achievement of applicable performance criteria. F2 · derivative.exercise_date: On December 10, 2023, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of fiscal year 2026, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date. F2 · derivative.expiration_date: On December 10, 2023, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of fiscal year 2026, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date. Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 22:11 UTC |
Aranki Karen LChief Human Resources Officer
|
GrantRestricted Stock Units · Derivative | 21,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-25-000123 · wk-form4_1765577476.xml · derivative · entry 4 Aranki Karen L · CIK 0002011723 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,875 Underlying: Common Stock · 21,875 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: These Restricted Stock Units granted on December 10, 2025 are scheduled to vest 50% on December 10, 2027 and 50% on December 10, 2029. Vested shares will be delivered to the reporting person upon vest date. F4 · derivative.expiration_date: These Restricted Stock Units granted on December 10, 2025 are scheduled to vest 50% on December 10, 2027 and 50% on December 10, 2029. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 22:11 UTC |
Aranki Karen LChief Human Resources Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 6,665 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-25-000123 · wk-form4_1765577476.xml · derivative · entry 3 Aranki Karen L · CIK 0002011723 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,666 Underlying: Common Stock · 6,665 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Restricted Stock Units granted on December 10, 2023 vested 50% on December 10, 2025, with the remaining 50% scheduled to vest 50% on December 10, 2027. Vested shares will be delivered to the reporting person upon vest. F3 · derivative.expiration_date: These Restricted Stock Units granted on December 10, 2023 vested 50% on December 10, 2025, with the remaining 50% scheduled to vest 50% on December 10, 2027. Vested shares will be delivered to the reporting person upon vest. Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 22:11 UTC |
Aranki Karen LChief Human Resources Officer
|
Tax withholdingCommon Stock | 1,923 | $11.70 | $22,499.10 |
DisclosureSEC source: 0001681622-25-000123 · wk-form4_1765577476.xml · nonDerivative · entry 2 Aranki Karen L · CIK 0002011723 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,919 F2 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 22:11 UTC |
Aranki Karen LChief Human Resources Officer
|
Exercise / conversionCommon Stock | 6,665 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-25-000123 · wk-form4_1765577476.xml · nonDerivative · entry 1 Aranki Karen L · CIK 0002011723 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,842 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 17:11 UTC |
Jonaitis Mark S.SVP and GM, X-Ray Sources
|
GrantRestricted Stock Units · Derivative | 26,041 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-25-000127 · wk-form4_1765577505.xml · derivative · entry 6 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,041 Underlying: Common Stock · 26,041 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F6 · derivative.exercise_date: These Restricted Stock Units granted on December 10, 2025 are scheduled to vest 50% on December 10, 2027 and 50% on December 10, 2029. Vested shares will be delivered to the reporting person upon vest date. F6 · derivative.expiration_date: These Restricted Stock Units granted on December 10, 2025 are scheduled to vest 50% on December 10, 2027 and 50% on December 10, 2029. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 17:11 UTC |
Jonaitis Mark S.SVP and GM, X-Ray Sources
|
Exercise / conversionRestricted Stock Units · Derivative | 7,935 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-25-000127 · wk-form4_1765577505.xml · derivative · entry 5 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,936 Underlying: Common Stock · 7,935 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F5 · derivative.exercise_date: These Restricted Stock Units granted on December 10, 2023 vested 50% on December 10, 2025, with the remaining 50% scheduled to vest on December 10, 2027. Vested shares will be delivered to the reporting person upon vest date. F5 · derivative.expiration_date: These Restricted Stock Units granted on December 10, 2023 vested 50% on December 10, 2025, with the remaining 50% scheduled to vest on December 10, 2027. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 17:11 UTC |
Jonaitis Mark S.SVP and GM, X-Ray Sources
|
Exercise / conversionRestricted Stock Units · Derivative | 4,664 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-25-000127 · wk-form4_1765577505.xml · derivative · entry 4 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,664 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: These Restricted Stock Units granted on December 10, 2021 vested 50% on December 10, 2023 and 50% on December 10, 2025. Vested shares will be delivered to the reporting person upon vest date. F4 · derivative.expiration_date: These Restricted Stock Units granted on December 10, 2021 vested 50% on December 10, 2023 and 50% on December 10, 2025. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 17:11 UTC |
Jonaitis Mark S.SVP and GM, X-Ray Sources
|
Tax withholdingCommon Stock | 5,526 | $11.70 | $64,654.20 |
DisclosureSEC source: 0001681622-25-000127 · wk-form4_1765577505.xml · nonDerivative · entry 3 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,341 F3 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 17:11 UTC |
Jonaitis Mark S.SVP and GM, X-Ray Sources
|
Exercise / conversionCommon Stock | 7,935 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-25-000127 · wk-form4_1765577505.xml · nonDerivative · entry 2 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,867 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 17:11 UTC |
Jonaitis Mark S.SVP and GM, X-Ray Sources
|
Exercise / conversionCommon Stock | 4,664 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-25-000127 · wk-form4_1765577505.xml · nonDerivative · entry 1 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,932 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F2 · balance_after: Includes 2,100 shares purchased under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan since the last Form 4 filing of the reporting person. Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 17:11 UTC |
SANYAL SUNNYDirector · President and CEO
|
GrantRestricted Stock Units · Derivative | 156,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-25-000125 · wk-form4_1765577489.xml · derivative · entry 6 SANYAL SUNNY · CIK 0001599398 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,250 Underlying: Common Stock · 156,250 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F5 · derivative.exercise_date: These Restricted Stock Units granted on December 10, 2025 are scheduled to vest 50% on December 10, 2027 and 50% on December 10, 2029. Vested shares will be delivered to the reporting person upon vest date. F5 · derivative.expiration_date: These Restricted Stock Units granted on December 10, 2025 are scheduled to vest 50% on December 10, 2027 and 50% on December 10, 2029. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 17:11 UTC |
SANYAL SUNNYDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 47,613 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-25-000125 · wk-form4_1765577489.xml · derivative · entry 5 SANYAL SUNNY · CIK 0001599398 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,613 Underlying: Common Stock · 47,613 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: These Restricted Stock Units granted on December 10, 2023 vested 50% on December 10, 2025, with the remaining 50% scheduled to vest on December 10, 2027. Vested shares will be delivered to the reporting person upon vest date. F4 · derivative.expiration_date: These Restricted Stock Units granted on December 10, 2023 vested 50% on December 10, 2025, with the remaining 50% scheduled to vest on December 10, 2027. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.